Group One Trading, L.P. Pyxis Oncology, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 602 shares of PYXS stock, worth $2,034. This represents 0.0% of its overall portfolio holdings.
Number of Shares
602
Previous 3,010
80.0%
Holding current value
$2,034
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PYXS
# of Institutions
74Shares Held
22.9MCall Options Held
0Put Options Held
0-
Laurion Capital Management LP New York, NY3.63MShares$12.3 Million0.07% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.54MShares$12 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$9.42 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.5MShares$8.45 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$7.26 Million0.0% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $119M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...